文献速递精神分裂症与精神病性障碍

针对精神病性障碍患者听幻觉的心理干预:系统综述与Meta分析

Psychological Interventions Targeting Auditory Hallucinations in Persons With Psychotic Disorders: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Psychiatry · 2026-01-01

该系统综述与Meta分析纳入23项随机临床试验共2016名成人精神分裂症谱系障碍患者,评估针对听幻觉的心理社会干预的疗效与可接受性。

要点

  • 针对性心理干预可小幅降低听幻觉严重度,NNT=16,证据等级为低。
  • 化身疗法在降低听幻觉严重度上效应量最大(SMD=-0.37)。
  • 干预对听幻觉频率、痛苦及阳性症状、抑郁、焦虑等次要结局也有效。

核心结论

  • 针对精神分裂症谱系障碍听幻觉的心理社会干预有效,效应量小到中等,但不同方法间差异显著。
  • 化身疗法在改善听幻觉症状方面似乎尤为有效。

研究设计与样本

  • 系统综述与随机效应Meta分析,遵循PRISMA,检索Embase、MEDLINE等数据库至2025年8月18日。
  • 纳入23项随机临床试验,共2016名成人精神分裂症谱系障碍患者,干预组1081例、对照组935例,涵盖5种治疗方法。

主要发现

  • 干预对听幻觉频率与痛苦、总症状、阳性症状、妄想、抑郁及焦虑等多个次要结局也显示效应。
  • 敏感性分析提示结果稳健,脱落率与不良事件报告提示治疗耐受性和可接受性高。

关键数值与推荐

  • 主要结局为后治疗与随访时听幻觉及临床特征的组间差异,采用效度良好的评定量表测量。
  • 采用Hedges g进行随机效应Meta分析,并计算需治疗人数(NNT)及GRADE证据确定性评级。

临床怎么用

  • 临床可考虑将针对性心理社会干预用于精神分裂症谱系障碍患者的听幻觉管理。
  • 化身疗法可作为改善听幻觉症状的优先选择之一,但需结合低证据等级审慎解读。

局限性

  • 主要结局证据确定性为GRADE低证据。
  • 不同治疗方法间效应差异显著,可能限制整体结论的推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Auditory hallucinations (AHs) are a hallmark characteristic of schizophrenia spectrum disorders (SSDs) and are often associated with severe distress. Previous research lacks comprehensive evidence on the overall efficacy of approaches targeting AHs in SSDs. OBJECTIVE: To evaluate the efficacy and acceptability of all available psychological and psychosocial interventions targeting AHs in SSDs. DATA SOURCES: Embase, MEDLINE, PsycArticles, PsycInfo, PSYNDEX, and the Cochrane library were searched for eligible studies published until August 18, 2025. STUDY SELECTION: Randomized clinical trials that analyzed psychological interventions targeting AHs compared to controls in adults with SSDs. DATA EXTRACTION AND SYNTHESIS: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Two independent reviewers screened publications, extracted data, and assessed risk of bias. A random-effects meta-analysis was performed (Hedges g). MAIN OUTCOMES AND MEASURES: The main outcomes were between-group differences in AHs and clinical characteristics at posttreatment and follow-up, measured with validated rating scales. Additional number-needed-to-treat (NNT) analyses and rating of evidence certainty (GRADE approach) were conducted. RESULTS: A total of 23 studies with 2016 participants were included, with 1081 in the intervention groups across 5 different therapeutic approaches and 935 in the control groups. At posttreatment, targeted interventions reduced the severity of AHs compared with control groups (standardized mean difference [SMD], -0.18; 95% CI, -0.31 to -0.05; P = .007; NNT, 16; GRADE, low evidence). This effect was also observed for numerous secondary outcomes, comprising frequency and distress of AHs, total symptoms, positive symptoms, delusions, depression, and anxiety. Subgroup analysis showed that avatar therapy reduced the severity of AHs with the largest effect size (SMD, -0.37; 95% CI, -0.51 to -0.22; P < .001). Sensitivity analyses indicated robustness of results. Dropout rates and reports on adverse events indicated high tolerability and acceptability of treatments. CONCLUSION AND RELEVANCE: Although targeted psychological and psychosocial interventions for AHs in SSDs were found to be effective in reducing the severity and other characteristics of AHs, with effect sizes ranging from small to medium, substantial differences were observed between approaches. In particular, avatar therapy seems to be effective at addressing AH symptoms. These findings could influence future studies and clinical care by advancing the development of targeted, novel approaches for AHs that address relevant treatment characteristics.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fässler L, Koop S, Opper F, et al. Psychological Interventions Targeting Auditory Hallucinations in Persons With Psychotic Disorders: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2026. PMID: 42307965. doi:10.1001/jamapsychiatry.2026.1443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。